The EXACT-Pro: Measuring exacerbations of COPD

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 3, 2011, Pages 287-288

  Celli, Bartolome R ^a   Vestbo, Jørgen ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE EXACERBATION; DYSPNEA; EDITORIAL; EXACERBATION OF CHRONIC PULMONARY DISEASE TOOL; GOLD STANDARD; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SELF REPORT; SLEEP DISORDER; SPUTUM; SYMPTOMATOLOGY; VALIDITY; WEAKNESS;

DISEASE PROGRESSION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 79551538993     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201009-1401ED     Document Type: Editorial

References (10)

1. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
2. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S.
3. Burge S, Wedzicha J. COPD exacerbations: definition and classifications. Eur Respir J 2003;41:43S-53S.
4. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009;64:956-962.
5. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224-1238.
6. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-1613.
7. Vijayasaratha K, Stockley RA. Reported and unreported exacerbations of COPD: analysis by diary cards. Chest 2008;133:34-41.
8. Food and Drug Administration (FDA). Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist 2009;74:65132-65133.
9. Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K, Petrillo J, Powers J, Sethi S; EXACT-PRO Study Group. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health (In press)
10. Leidy N, Wilcox T, Jones P, Roberts L, Powers J, Sethi S. Standardizing measurement of COPD exacerbations: reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2010;183:323-329.